At this time, most clinical trial plans stick to ICH rules, targeted at "making certain that good quality, Harmless and helpful medicines are produced and registered in one of the most successful and value-effective way. These functions are pursued while in the interest of The buyer and public health, to stop avoidable duplication of clinical trial